Phenol sulphotransferase SULT1A1*1 genotype is associated with reduced risk of colorectal cancer

Pharmacogenetics

Volumn 11, Issue 8, 2001, Pages 679-685

  Bamber, D E ^a   Fryer, A A ^a   Strange, R C ^a   Elder, J B ^a   Deakin, M ^a   Rajagopal, R ^a   Fawole, A ^a   Gilissen, R A H J ^a   Campbell, F C ^a   Coughtrie, M W H ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Colorectal cancer; Sulphation; Sulphotransferase; Susceptibility

Indexed keywords

ARYL SULFOTRANSFERASE;

ADULT; AGED; ALLELE; ARTICLE; CANCER CLASSIFICATION; CANCER LOCALIZATION; CANCER RISK; CANCER SURVIVAL; CANCER SUSCEPTIBILITY; CARCINOGENESIS; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; GENE ACTIVITY; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOSITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MUTAGENICITY; PRIORITY JOURNAL; RISK ASSESSMENT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; ARYLSULFOTRANSFERASE; COLORECTAL NEOPLASMS; FEMALE; GENETIC SCREENING; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; SEX FACTORS; SULFOTRANSFERASES;

EID: 0035175340     PISSN: 0960314X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008571-200111000-00006     Document Type: Article

References (27)

1. Kiras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: A Southwest Oncology Group study
2. Glutathione S-transferase M1 and T1 polymorphisms: Susceptibility to colon cancer and age of onset
3. Metabolic activation of N-hydroxy arylamines and N -hydroxy heterocyclic amines by human sulfotransferase(s)
4. Sulphation catalysed by the human cytosolic sulphotransferases - Chemical defence or molecular terrorism?
5. Interactions between dietary chemicals and human sulfotransferases - Molecular mechanisms and clinical significance
6. Biology and function of the reversible sulfation pathway catalysed by human sulfotransferases and sulfatases
7. Phenol sulphotransferase SULT1A1 polymorphism: Molecular diagnosis and allele frequencies in Caucasian and African populations
8. Association between functional genetic polymorphisms of human sulfotransferases 1A1 and 1A2
9. Enzymology of human cytosolic sulfotransferases
10. Health risks of heterocyclic amines
11. Metabolic differences and their impact on human disease - Sulfotransferase and colorectal cancer
12. Sulfation of aromatic hydroxamic acids and hydroxylamines by multiple forms of human liver sulfotransferases
13. Assessing human risk to heterocyclic amines
14. Metabolism of carcinogenic heterocyclic and aromatic amines by recombinant human cytochrome P450 enzymes
15. Activity of phenolsulfotransferases in the human gastrointestinal tract
16. Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases
17. The human phenolsulfotransferase polymorphism is determined by the level of expression of the enzyme protein
18. Specific 5′-GGGA-3′->5′-GGA-3′ mutation of the Apc gene in rat colon tumors induced by 2-amino-1-methyl-6-phenylimidazo[4,5-b ]pyridine
19. Phenol sulfotransferase pharmacogenetics in humans: Association of common SULT1A1 alleles with TS PST phenotype
20. Human phenol sulfotransferases SULT1A2 and SULT1A1. Genetic polymorphisms, allozyme properties, and human liver genotype-phenotype correlations
21. Phenol sulfotransferases: Hormonal regulation, polymorphism, and age of onset of breast cancer
22. Phenol sulphotransferase SULT1A1 polymorphism in prostate cancer: Lack of association
23. Urinary excretion of unmetabolized and phase II conjugates of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 2-amino-3,8-dimethylimidazo[4,5- f]quinoxaline in humans: Relationship to cytochrome P4501A2 and N -acetyltransferase activity
24. Food-derived mutagens and carcinogens
25. Sulfotransferase molecular biology: cDNAs and genes
26. Glutathione S-transferase T1 and M1 genotypes in normal mucosa, transitional mucosa and colorectal adenocarcinoma
27. Sulfotransferase 1A1 polymorphism, endogenous estrogen exposure, well-done meat intake, and breast cancer risk